Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Important role of Nfkb2 in the KrasG12D-driven carcinogenesis in the pancreas.
Hassan Z, Schneeweis C, Wirth M, Müller S, Geismann C, Neuß T, Steiger K, Krämer OH, Schmid RM, Rad R, Arlt A, Reichert M, Saur D, Schneider G. Hassan Z, et al. Among authors: kramer oh. Pancreatology. 2021 Aug;21(5):912-919. doi: 10.1016/j.pan.2021.03.012. Epub 2021 Mar 26. Pancreatology. 2021. PMID: 33824054 Free article.
Targeting histone deacetylases in pancreatic ductal adenocarcinoma.
Schneider G, Krämer OH, Fritsche P, Schüler S, Schmid RM, Saur D. Schneider G, et al. Among authors: kramer oh. J Cell Mol Med. 2010 Jun;14(6A):1255-63. doi: 10.1111/j.1582-4934.2009.00974.x. Epub 2009 Nov 19. J Cell Mol Med. 2010. PMID: 19929947 Free PMC article. Review.
Cross talk between stimulated NF-kappaB and the tumor suppressor p53.
Schneider G, Henrich A, Greiner G, Wolf V, Lovas A, Wieczorek M, Wagner T, Reichardt S, von Werder A, Schmid RM, Weih F, Heinzel T, Saur D, Krämer OH. Schneider G, et al. Among authors: kramer oh. Oncogene. 2010 May 13;29(19):2795-806. doi: 10.1038/onc.2010.46. Epub 2010 Mar 1. Oncogene. 2010. PMID: 20190799
Inhibitors of HDACs--effective drugs against cancer?
Müller S, Krämer OH. Müller S, et al. Among authors: kramer oh. Curr Cancer Drug Targets. 2010 Mar;10(2):210-28. doi: 10.2174/156800910791054149. Curr Cancer Drug Targets. 2010. PMID: 20201785 Review.
NFκB/p53 crosstalk-a promising new therapeutic target.
Schneider G, Krämer OH. Schneider G, et al. Among authors: kramer oh. Biochim Biophys Acta. 2011 Jan;1815(1):90-103. doi: 10.1016/j.bbcan.2010.10.003. Epub 2010 Oct 15. Biochim Biophys Acta. 2011. PMID: 20951769 Review.
A combination of a ribonucleotide reductase inhibitor and histone deacetylase inhibitors downregulates EGFR and triggers BIM-dependent apoptosis in head and neck cancer.
Stauber RH, Knauer SK, Habtemichael N, Bier C, Unruhe B, Weisheit S, Spange S, Nonnenmacher F, Fetz V, Ginter T, Reichardt S, Liebmann C, Schneider G, Krämer OH. Stauber RH, et al. Among authors: kramer oh. Oncotarget. 2012 Jan;3(1):31-43. doi: 10.18632/oncotarget.430. Oncotarget. 2012. PMID: 22289787 Free PMC article.
149 results